+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Brain Tumor Diagnosis & Therapeutics Market Research Report by Type (Diagnosis and Therapeutics), Therapeutics, Diagnosis, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

  • PDF Icon

    Report

  • 236 Pages
  • January 2023
  • Region: Global
  • 360iResearch™
  • ID: 5313861
UP TO OFF until Mar 31st 2023
The Global Brain Tumor Diagnosis & Therapeutics Market size was estimated at USD 1,497.34 million in 2022, USD 1,635.44 million in 2023, and is projected to grow at a CAGR of 9.35% to reach USD 3,063.22 million by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Brain Tumor Diagnosis & Therapeutics Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Brain Tumor Diagnosis & Therapeutics Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Brain Tumor Diagnosis & Therapeutics Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Brain Tumor Diagnosis & Therapeutics Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for the market plan. This research report categorizes the Global Brain Tumor Diagnosis & Therapeutics Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market is studied across Diagnosis and Therapeutics. The Diagnosis is further studied across Cerebral Arteriogram, CT Scan, EEG, Lumbar Puncture, Molecular Testing, MRI, PET-CT Scan, and Tissue Sampling. The Therapeutics is further studied across Chemotherapy, Immunotherapy, Radiation Therapy, Surgery, and Targeted Therapy.
  • Based on Therapeutics, the market is studied across Chemotherapy, Immunotherapy, Radiation Therapy, Surgery, and Targeted Therapy.
  • Based on Diagnosis, the market is studied across CT Scan, EEG, Molecular Testing, MRI, and PET-CT Scan.
  • Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Brain Tumor Diagnosis & Therapeutics Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Brain Tumor Diagnosis & Therapeutics Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Brain Tumor Diagnosis & Therapeutics Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Brain Tumor Diagnosis & Therapeutics Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Brain Tumor Diagnosis & Therapeutics Market, including AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Co, Carestream Health, Inc., Eisai Co., Ltd., F. Hoffmann-La Roche AG, Fujifilm Corporation, GE Healthcare Inc., GlaxoSmithKline PLC, Johnson & Johnson, Koninklijke Philips N.V., Merck & Co. Inc., Novartis AG, Pfizer, Inc., S&P Global Inc., Shimadzu Corporation, and Siemens Healthineers AG.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Brain Tumor Diagnosis & Therapeutics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Brain Tumor Diagnosis & Therapeutics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Brain Tumor Diagnosis & Therapeutics Market?
4. What is the competitive strategic window for opportunities in the Global Brain Tumor Diagnosis & Therapeutics Market?
5. What are the technology trends and regulatory frameworks in the Global Brain Tumor Diagnosis & Therapeutics Market?
6. What is the market share of the leading vendors in the Global Brain Tumor Diagnosis & Therapeutics Market?
7. What modes and strategic moves are considered suitable for entering the Global Brain Tumor Diagnosis & Therapeutics Market?
Frequently Asked Questions about the Global Brain Tumor Diagnosis & Therapeutics Market

What is the estimated value of the Global Brain Tumor Diagnosis & Therapeutics Market?

The Global Brain Tumor Diagnosis & Therapeutics Market was estimated to be valued at $1497.34 Million in 2022.

What is the growth rate of the Global Brain Tumor Diagnosis & Therapeutics Market?

The growth rate of the Global Brain Tumor Diagnosis & Therapeutics Market is 9.3%, with an estimated value of $3063.22 Million by 2030.

What is the forecasted size of the Global Brain Tumor Diagnosis & Therapeutics Market?

The Global Brain Tumor Diagnosis & Therapeutics Market is estimated to be worth $3063.22 Million by 2030.

Who are the key companies in the Global Brain Tumor Diagnosis & Therapeutics Market?

Key companies in the Global Brain Tumor Diagnosis & Therapeutics Market include AstraZeneca PLC, Bayer AG, Bristol, Myers Squibb Co, Carestream Health, Inc., Eisai Co., Ltd., F. Hoffmann, La Roche AG and GE Healthcare Inc..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of neurological disorders
5.1.1.2. Need for tests detecting the presence of tumors
5.1.1.3. Research activities in the molecular diagnostics
5.1.2. Restraints
5.1.2.1. High cost associated with the diagnosis and treatment
5.1.3. Opportunities
5.1.3.1. Rising healthcare expenditure and the favorable reimbursement policies
5.1.3.2. Government initiatives for cancer awareness
5.1.4. Challenges
5.1.4.1. Side effects associated with brain tumor therapeutics
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Brain Tumor Diagnosis & Therapeutics Market, by Type
6.1. Introduction
6.2. Diagnosis
6.3.1. Cerebral Arteriogram
6.3.2. CT Scan
6.3.3. EEG
6.3.4. Lumbar Puncture
6.3.5. Molecular Testing
6.3.6. MRI
6.3.7. PET-CT Scan
6.3.8. Tissue Sampling
6.3. Therapeutics
6.4.1. Chemotherapy
6.4.2. Immunotherapy
6.4.3. Radiation Therapy
6.4.4. Surgery
6.4.5. Targeted Therapy

7. Brain Tumor Diagnosis & Therapeutics Market, by Therapeutics
7.1. Introduction
7.2. Chemotherapy
7.3. Immunotherapy
7.4. Radiation Therapy
7.5. Surgery
7.6. Targeted Therapy

8. Brain Tumor Diagnosis & Therapeutics Market, by Diagnosis
8.1. Introduction
8.2. CT Scan
8.3. EEG
8.4. Molecular Testing
8.5. MRI
8.6. PET-CT Scan

9. Americas Brain Tumor Diagnosis & Therapeutics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Brain Tumor Diagnosis & Therapeutics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Brain Tumor Diagnosis & Therapeutics Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Product Portfolio Analysis, By Key Player
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. AstraZeneca PLC
13.2. Bayer AG
13.3. Bristol-Myers Squibb Co
13.4. Carestream Health, Inc.
13.5. Eisai Co., Ltd.
13.6. F. Hoffmann-La Roche AG
13.7. Fujifilm Corporation
13.8. GE Healthcare Inc.
13.9. GlaxoSmithKline PLC
13.10. Johnson & Johnson
13.11. Koninklijke Philips N.V.
13.12. Merck & Co. Inc.
13.13. Novartis AG
13.14. Pfizer, Inc.
13.15. S&P Global Inc.
13.16. Shimadzu Corporation
13.17. Siemens Healthineers AG

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2022 VS 2030
FIGURE 3. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
FIGURE 7. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 8. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 10. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET DYNAMICS
FIGURE 11. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 13. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY TYPE, 2030
FIGURE 15. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
FIGURE 16. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY CEREBRAL ARTERIOGRAM, 2018-2030 (USD MILLION)
FIGURE 17. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY CT SCAN, 2018-2030 (USD MILLION)
FIGURE 18. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY EEG, 2018-2030 (USD MILLION)
FIGURE 19. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY LUMBAR PUNCTURE, 2018-2030 (USD MILLION)
FIGURE 20. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY MOLECULAR TESTING, 2018-2030 (USD MILLION)
FIGURE 21. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY MRI, 2018-2030 (USD MILLION)
FIGURE 22. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY PET-CT SCAN, 2018-2030 (USD MILLION)
FIGURE 23. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TISSUE SAMPLING, 2018-2030 (USD MILLION)
FIGURE 24. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
FIGURE 25. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
FIGURE 26. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
FIGURE 27. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY RADIATION THERAPY, 2018-2030 (USD MILLION)
FIGURE 28. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
FIGURE 29. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
FIGURE 30. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2022 VS 2030 (%)
FIGURE 31. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 32. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY THERAPEUTICS, 2030
FIGURE 33. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
FIGURE 34. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
FIGURE 35. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY RADIATION THERAPY, 2018-2030 (USD MILLION)
FIGURE 36. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
FIGURE 37. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
FIGURE 38. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2022 VS 2030 (%)
FIGURE 39. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 40. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY DIAGNOSIS, 2030
FIGURE 41. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY CT SCAN, 2018-2030 (USD MILLION)
FIGURE 42. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY EEG, 2018-2030 (USD MILLION)
FIGURE 43. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY MOLECULAR TESTING, 2018-2030 (USD MILLION)
FIGURE 44. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY MRI, 2018-2030 (USD MILLION)
FIGURE 45. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY PET-CT SCAN, 2018-2030 (USD MILLION)
FIGURE 46. AMERICAS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 47. AMERICAS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 48. AMERICAS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 49. AMERICAS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 50. ARGENTINA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 51. BRAZIL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 52. CANADA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 53. MEXICO BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 54. UNITED STATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 55. UNITED STATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 56. UNITED STATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 57. UNITED STATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 58. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 59. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 60. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 61. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 62. AUSTRALIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 63. CHINA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 64. INDIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 65. INDONESIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 66. JAPAN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 67. MALAYSIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 68. PHILIPPINES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 69. SINGAPORE BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 70. SOUTH KOREA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 71. TAIWAN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 72. THAILAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 73. VIETNAM BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 74. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 75. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 76. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 77. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 78. DENMARK BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 79. EGYPT BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 80. FINLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 81. FRANCE BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 82. GERMANY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 83. ISRAEL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 84. ITALY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 85. NETHERLANDS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 86. NIGERIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 87. NORWAY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 88. POLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 89. QATAR BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 90. RUSSIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 91. SAUDI ARABIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 92. SOUTH AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 93. SPAIN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 94. SWEDEN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 95. SWITZERLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 96. TURKEY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 97. UNITED ARAB EMIRATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 98. UNITED KINGDOM BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 99. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 100. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 101. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY CEREBRAL ARTERIOGRAM, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY CEREBRAL ARTERIOGRAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY CEREBRAL ARTERIOGRAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY CT SCAN, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY CT SCAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY CT SCAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY EEG, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY EEG, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY EEG, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY LUMBAR PUNCTURE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY LUMBAR PUNCTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY LUMBAR PUNCTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY MOLECULAR TESTING, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY MOLECULAR TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY MOLECULAR TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY MRI, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY MRI, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY MRI, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY PET-CT SCAN, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY PET-CT SCAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY PET-CT SCAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TISSUE SAMPLING, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TISSUE SAMPLING, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TISSUE SAMPLING, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY RADIATION THERAPY, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY RADIATION THERAPY, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY CT SCAN, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY CT SCAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY CT SCAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY EEG, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY EEG, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY EEG, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY MOLECULAR TESTING, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY MOLECULAR TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY MOLECULAR TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY MRI, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY MRI, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY MRI, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY PET-CT SCAN, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY PET-CT SCAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY PET-CT SCAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 97. CANADA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 98. CANADA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. CANADA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 100. CANADA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 101. MEXICO BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 102. MEXICO BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. MEXICO BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 104. MEXICO BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 110. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 112. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 114. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 115. AUSTRALIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 116. AUSTRALIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. AUSTRALIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 118. AUSTRALIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 119. CHINA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 120. CHINA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. CHINA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 122. CHINA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 123. INDIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 124. INDIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. INDIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 126. INDIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 127. INDONESIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 128. INDONESIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 129. INDONESIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 130. INDONESIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 131. JAPAN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 132. JAPAN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. JAPAN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 134. JAPAN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 135. MALAYSIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 136. MALAYSIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 137. MALAYSIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 138. MALAYSIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 139. PHILIPPINES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 140. PHILIPPINES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. PHILIPPINES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 142. PHILIPPINES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 143. SINGAPORE BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 144. SINGAPORE BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 145. SINGAPORE BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 146. SINGAPORE BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 147. SOUTH KOREA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 148. SOUTH KOREA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 149. SOUTH KOREA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 150. SOUTH KOREA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 151. TAIWAN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 152. TAIWAN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 153. TAIWAN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 154. TAIWAN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 155. THAILAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 156. THAILAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 157. THAILAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 158. THAILAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 159. VIETNAM BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 160. VIETNAM BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 161. VIETNAM BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 162. VIETNAM BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 168. DENMARK BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 169. DENMARK BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 170. DENMARK BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 171. DENMARK BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 172. EGYPT BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 173. EGYPT BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 174. EGYPT BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 175. EGYPT BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 176. FINLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 177. FINLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 178. FINLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 179. FINLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 180. FRANCE BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 181. FRANCE BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 182. FRANCE BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 183. FRANCE BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 184. GERMANY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 185. GERMANY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 186. GERMANY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 187. GERMANY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 189. ISRAEL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 190. ISRAEL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 191. ISRAEL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 192. ITALY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 193. ITALY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 194. ITALY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 195. ITALY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 200. NIGERIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 201. NIGERIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 202. NIGERIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 204. NORWAY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 205. NORWAY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 206. NORWAY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 207. NORWAY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 208. POLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 209. POLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 210. POLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 211. POLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 212. QATAR BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 213. QATAR BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 214. QATAR BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 215. QATAR BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 216. RUSSIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 217. RUSSIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 218. RUSSIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 219. RUSSIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 220. SAUDI ARABIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 221. SAUDI ARABIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 222. SAUDI ARABIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 223. SAUDI ARABIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 224. SOUTH AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 225. SOUTH AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 226. SOUTH AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 227. SOUTH AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 228. SPAIN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 229. SPAIN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 230. SPAIN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 231. SPAIN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 232. SWEDEN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 233. SWEDEN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 234. SWEDEN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 235. SWEDEN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 236. SWITZERLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 237. SWITZERLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 238. SWITZERLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 239. SWITZERLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 240. TURKEY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 241. TURKEY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 242. TURKEY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 243. TURKEY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 244. UNITED ARAB EMIRATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 245. UNITED ARAB EMIRATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 248. UNITED KINGDOM BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 250. UNITED KINGDOM BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 252. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 253. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 254. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 255. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET RANKING, BY KEY PLAYER, 2022
TABLE 256. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 257. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 258. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET MERGER & ACQUISITION
TABLE 259. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 260. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 261. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET INVESTMENT & FUNDING
TABLE 262. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 263. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET: LICENSE & PRICING

Companies Mentioned

  • AstraZeneca PLC
  • Bayer AG
  • Bristol-Myers Squibb Co
  • Carestream Health, Inc.
  • Eisai Co., Ltd.
  • F. Hoffmann-La Roche AG
  • Fujifilm Corporation
  • GE Healthcare Inc.
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Koninklijke Philips N.V.
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer, Inc.
  • S&P Global Inc.
  • Shimadzu Corporation
  • Siemens Healthineers AG

Methodology

Loading
LOADING...